McMahon Robert W. 4

What Happened

• Robert W. McMahon, Chief Financial Officer of West Pharmaceutical Services, received two grants of restricted stock units (derivative awards) on 2026-03-01: 3,082 RSUs and 7,337 RSUs, for a total of 10,419 RSUs. The grants are reported at $0.00 (compensation awards), meaning no cash was exchanged at grant.

Key Details

• Transaction date and type: 2026-03-01 — Grant/Award (code A).
• Amounts/prices: 3,082 RSUs @ $0.00 and 7,337 RSUs @ $0.00; total 10,419 RSUs; no cash value reported on the Form 4.
• Shares owned after transaction: Not disclosed in this filing.
• Footnotes: F1 — each RSU is a contingent right to one share; F2 — RSUs vest in four equal annual installments beginning March 1, 2027; F3 — filing also notes a stock option vesting schedule (four equal annual installments beginning March 1, 2027).
• Filing timeliness: Form filed 2026-03-03 for 2026-03-01 transactions; no late filing indicated.

Context

• RSUs are a form of executive compensation, converting to actual shares only as they vest; they are not an immediate purchase or sale and should be interpreted as compensation rather than a direct market sentiment signal.